News from bionity.com

PreOmics announces early investors’ exit and closing of Series B financing

PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation. PreOmics was founded in 2016 by Dr....

more…

Forever Young: a new genetic brake for an ageing immune system

In a world with an ageing global population, we could all use some good news when it comes to age-related health. The latest findings in a study led by Dr Feng Hefeng at the Luxembourg Institute of Health’s (LIH) Immune Systems Biology Group could be just the tonic, having identified surprising age-...

more…

The two startups NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration As part of the collaboration, Phor...

more…

Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Evotec SE announced that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes.  The collaboration leverages Evotec’s extensive experience and track record of delivering in the field of m...

more…

Researchers use ghost imaging to speed up X-ray fluorescence chemical mapping

Researchers have developed a new, focus-free technique for creating chemical maps using x-ray fluorescence. The approach offers fast, high-resolution measurements, which could be useful for analyzing chemical composition for a range of applications in biomedicine, materials science, archeology, art ...

more…

Lifespin secures bridge financing

Lifespin GmbH in BioPark Regensburg has successfully concluded bridge financing to a total of € 2.5 million. The diagnostic data company is working successfully on an AI-based health platform that can measure important metabolic parameters in patients and expects to start series A in the funding cyc...

more…

CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry

CureVac N.V. announced that the company’s Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022. Mariola exits her role at CureVac after nearly 16 years of scientific leadership at the company, and 33 years in Germany, with plans to pursue a family ...

more…

Evonik builds world's first industrial-scale production plant for rhamnolipids

Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as active ingred...

more…

A spray to protect against lung damage from Covid-19

rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of the drug...

more…

Scientists dive deep into the different effects of morning and evening exercise

Exercise causes the body to release hundreds of different signals that improve our health in many different ways. Now scientists have mapped these intrinsic signals and how they are released by different organs in mice following exercise at different times of the day. Their ‘Atlas of Exercise Metabo...

more…